John den Engelsman

786 total citations
9 papers, 651 citations indexed

About

John den Engelsman is a scholar working on Molecular Biology, Pharmaceutical Science and Spectroscopy. According to data from OpenAlex, John den Engelsman has authored 9 papers receiving a total of 651 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 2 papers in Pharmaceutical Science and 2 papers in Spectroscopy. Recurrent topics in John den Engelsman's work include Heat shock proteins research (4 papers), Protein purification and stability (3 papers) and Analytical Chemistry and Chromatography (2 papers). John den Engelsman is often cited by papers focused on Heat shock proteins research (4 papers), Protein purification and stability (3 papers) and Analytical Chemistry and Chromatography (2 papers). John den Engelsman collaborates with scholars based in Netherlands, United States and United Kingdom. John den Engelsman's co-authors include Wilbert C. Boelens, Wilfried W. de Jong, Wim Jiskoot, Andreas Seidl, Hans Koll, Ronald Smulders, Patrick Garidel, Bryan Smith, Stefan Bassarab and Otmar Hainzl and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Journal of Molecular Biology.

In The Last Decade

John den Engelsman

9 papers receiving 631 citations

Peers

John den Engelsman
Krishna Balakrishnan United States
Shoshanna N. Zucker United States
Herald Reiersen United Kingdom
Giulio Preta Lithuania
Jun Yeul Lim South Korea
Krishna Balakrishnan United States
John den Engelsman
Citations per year, relative to John den Engelsman John den Engelsman (= 1×) peers Krishna Balakrishnan

Countries citing papers authored by John den Engelsman

Since Specialization
Citations

This map shows the geographic impact of John den Engelsman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John den Engelsman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John den Engelsman more than expected).

Fields of papers citing papers by John den Engelsman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John den Engelsman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John den Engelsman. The network helps show where John den Engelsman may publish in the future.

Co-authorship network of co-authors of John den Engelsman

This figure shows the co-authorship network connecting the top 25 collaborators of John den Engelsman. A scholar is included among the top collaborators of John den Engelsman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John den Engelsman. John den Engelsman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Weinbuch, Daniel, Jason K. Cheung, Vasco Filipe, et al.. (2015). Nanoparticulate Impurities in Pharmaceutical-Grade Sugars and their Interference with Light Scattering-Based Analysis of Protein Formulations. Pharmaceutical Research. 32(7). 2419–2427. 28 indexed citations
2.
Engelsman, John den, et al.. (2013). Pseudophosphorylated αB-Crystallin Is a Nuclear Chaperone Imported into the Nucleus with Help of the SMN Complex. PLoS ONE. 8(9). e73489–e73489. 14 indexed citations
3.
Kurkov, Sergey V., et al.. (2011). Evaluation of sugammadex self-association. International Journal of Pharmaceutics. 413(1-2). 134–139. 6 indexed citations
4.
Engelsman, John den, Patrick Garidel, Ronald Smulders, et al.. (2010). Strategies for the Assessment of Protein Aggregates in Pharmaceutical Biotech Product Development. Pharmaceutical Research. 28(4). 920–933. 290 indexed citations
5.
Tantipolphan, Ruedeeporn, Stefan Romeijn, John den Engelsman, et al.. (2010). Elution behavior of insulin on high-performance size exclusion chromatography at neutral pH. Journal of Pharmaceutical and Biomedical Analysis. 52(2). 195–202. 39 indexed citations
6.
Engelsman, John den, Sándor Boros, Patricia Y. W. Dankers, et al.. (2009). The Small Heat-Shock Proteins HSPB2 and HSPB3 Form Well-defined Heterooligomers in a Unique 3 to 1 Subunit Ratio. Journal of Molecular Biology. 393(5). 1022–1032. 42 indexed citations
7.
Engelsman, John den, Danny Gerrits, Wilfried W. de Jong, et al.. (2005). Nuclear Import of αB-crystallin Is Phosphorylation-dependent and Hampered by Hyperphosphorylation of the Myopathy-related Mutant R120G. Journal of Biological Chemistry. 280(44). 37139–37148. 63 indexed citations
8.
Engelsman, John den, Erik Bennink, Carla Onnekink, et al.. (2004). Mimicking phosphorylation of the small heat‐shock protein αB‐crystallin recruits the F‐box protein FBX4 to nuclear SC35 speckles. European Journal of Biochemistry. 271(21). 4195–4203. 61 indexed citations
9.
Engelsman, John den, V. Keijsers, Wilfried W. de Jong, & Wilbert C. Boelens. (2003). The Small Heat-shock Protein αB-Crystallin Promotes FBX4-dependent Ubiquitination. Journal of Biological Chemistry. 278(7). 4699–4704. 108 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026